Objective Red cell distribution widht (RDW) and neutrophil to lymphocyte ratio (NLR) plays a signifi cant role in assessing the severity and progression of some cardiac conditions. Bicuspid aortic valve (BAV)-associated aortopathy is common and its progression for individual patients is diffi cult to predict. In this study, we aimed to investigate the association between serum levels of RDW, NLR and ascending aortic diameter (AAd) in BAV patients. Sakarya Med J, 2018, 8(2):327-335 )
Introduction
Bicuspid aortic valve (BAV) represents the most frequent congenital heart malformation and as such it may be subject to valvular stenosis, regurgitation or infective endocarditis. 1, 2 Even in the absence of echocardiographically relevant valve dysfunction, it may be associated with ascending aorta dilatation (AAD) at different anatomical levels. 3 Dilatation of the tubular ascending aorta is the most frequent form of bicuspid aortopathy and simultaneously an issue of extensive and controversial debate. Moreover, even patients with functionally normal BAVs have been shown to present with larger aortic diameters both at baseline and during follow-up when compared with their controls. 4 The diversity of bicuspid aortopathy is closely related to the bicuspid valve morphology as well as the type of valvular dysfunction, while the progression rates of aortic dilatation may differ substantially. 5, 6 Red cell distribution widht (RDW) shows the variability in erythrocytes volume in the peripheral blood. Neutrophil to lymphocyte ratio (NLR), as an oxidative stress and proinfl ammatory marker, has recently emerged as a useful indicator to predict cardiovascular risk and adverse outcomes 7 .
Both RDW and NLR are easily available laboratory parameters and can be quickly measured in complete blood count (CBC) test. The prognostic importance of these markers have been reported in a novel study which show an association of RDW and NLR in patients with AAD before. 8 The correlation of RDW and NLR with infl ammatory markers has showed these markers to be indicators of chronic infl ammation in disease progression with high levels resulting in worse outcome.9
The relation of plasma levels of RDW and NLR with ascending aortic diameter (AAd) has not been established yet in patients with BAV. Therefore, in this study we aimed to investigate the association between these parameters and AAd in BAV patients.
Materials and Methods

Patient selection
At this descriptive and methodologic study we prospectively enrolled consecutive patients who were performed transthoracic echocardiographic examination and were diagnosed to have BAV between March 2015 and July 2017. Basic data and clinical history of these patients concerning age, gender, hypertension, diabetes mellitus, hyperlipidemia, cardiovascular diseases and smoking were noted. Patients with acute and/or chronic infl ammatory disease, connective tissue disease associated with AAD (Marfan syndrome, Behçet disease etc.), a malignancy, hematological disease, anemia, alcohol abuse, a history of renal and liver disease were excluded from this study.
The study was approved by the local ethics committee and informed consents of all subjects were obtained.
Echocardiographic examination
The patients with BAV were re-examined with transthoracic echocardiography by an independent and experienced cardiologist who was blinded to the clinical or laboratory fi ndings of the study population. The echocardiographic examinations were carried out using a 2.5 to 3. Ascending aortic dilatation was determined on demonstration of aortic enlargement relative to the expected aortic diameter based on age and body size adjusted nomograms as recommended by the American Heart Association (AHA) guidelines.
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Laboratory measurements
Venous blood samples were drawn into EDTA-treated or plain tubes according to hospital protocol from all participants at morning hours after a fasting period of 12 hours. Glucose, urea, creatinine 
Results
A total of 182 consecutive BAV patients were enrolled into this study. The mean age of the patients was 41.2 ± 12.4 (range 19-75) years and 68% of them was male. Among 182 patients, 45 with AAD were included into group 1 whereas remaining patients were included into group 2. The clinical and demographic characteristics of both groups are demonstrated in Table 1 . There were no signifi cant differences between the groups with respect to body mass index, smoking rate, heart rate, systolic and diastolic blood pressure and incidence of hypertension and diabetes mellitus.
The mean age of BAV patients with AAD was 47 ± 12 (range 22-65) years which was much higher than that of the BAV patients without AAD (p< 0.001). The rate of male patients were also signifi cantly higher in group 1 compared to group 2 patients (91% vs 67%, respectively, p= 0.002).
Moreover, the incidence of hyperlipidemia was signifi cantly higher in group 1 patients when it was compared to those in group 2 (51% vs 34%, respectively, p= 0.018). When echocardiographic parameters were compared, it was detected that LVEDD, LVESD, PoW, aortic annulus, ascending aorta and sinus of Valsalva diameters were signifi cantly higher whereas LVEF was signifi cantly lower in group 1 patients than those in group 2. However, LA diameter and IVS thickness were similar between groups. Mean AAd was 4.12 ± 0.27 cm (range 3.9-4.9 cm) in the AAD group and 3.31 ± 0.32 cm (range 2.1-3.8 cm) in patients without AAD. Only 6 patients in the AAD group (13%) had moderate to severe aortic regurgitation.
The laboratory parameters of the patient groups were listed in Table 2 . Accordingly, WBC count, neutrophil count and NLR (2.5 ± 1.6 vs 2.1 ± 0.7, respectively, p< 0.001) were signifi cantly higher in patients with AAD than those without. However, there was not statistically signifi cant differences in terms of haemoglobin, mean platelet volume, RDW levels and platelet count between the groups. When, lipid profi les were compared, total cholesterol, HDL cholesterol and TG levels were found to be similar whereas LDL cholesterol level was signifi cantly higher in group 1 patients than those in group 2 (127 ± 44 vs 107 ± 35 mg/dL, respectively, p= 0.004). Receiver operating characteristic (ROC) curve analysis revealed that a RDW measurement higher than >13.0% predicted AAD with a sensitivity of 52% and a specifi city of 79% (AUC 0.553, p= 0.027) in the study population (Figure) . In univariate correlation analysis, there were positive correlation between RDW levels and LVEDD However, correlation between RDW levels and AAd was only demonstrated in BAV patients with AAD that is group 1 ( Table 3) . 
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1.36-2.44, P = 0.01) remained as the independent markers of AAD in the study subjects (Table   4) . Hosmer and Lemeshow test statistic was 9.61 (df=8, p= 0.29), which shows good model fi t. Figure: Receiver operating characteristic curve of red cell distribution widht (RDW) for predicting ascending aortic dilatation in the study population.
Discussion
The main fi nding of our study was that both RDW and NLR are independently correlated with the AAd in patients with BAV and AAD. In addition, RDW was found to be an independent correlate of AAD in these patients. To our knowledge, this study is the fi rst to assess the relation of RDW values and NLR with dilated ascending aorta in BAV patients. Associated aortopathy is an important but still poorly understood problem that is frequently detected in BAV patients. More than one third of patients with a BAV have AAD. 13 we demonstrated RDW as an independent correlates of AAD in these patients. These laboratory parameters are easily available almost in all health centers and can be evaluated by only one tube CBC assay. These fi ndings may at least give a small clue about AAd in BAV patients with AAD and for that reason may be utilized as a routine assay at follow-ups of such patients.
Red blood cell distribution width is obtained from a standard CBC. It is a measure of the variability in size of circulating erythrocytes and is indicated as the coeffi cient of variation of the erythrocyte size. 15 It is routinely analyzed in CBC and utilized as a useful marker for differential diagnosis of anemia. 16, 17 Researchers attribute oxidative stress and infl ammation as the actual underlying mechanism in the predictive role of RDW as a potential prognostic marker in various diseases. 18, 19 There have been an increasing number of studies regarding the association between RDW and infl ammation and infl ammatory markers. Moreover, in a study increased levels of RDW levels was reported in patients with AAD.8 Although we did not fi nd a signifi cant difference in RDW levels in patient groups with and without AAD, we found a signifi cant correlation between RDW and AAd in BAV patients with AAD.
Proinfl ammatory status can be measured by using various biochemical and haematological markers. Although there are novel disease-specifi c biomarkers, most of these are time consuming and expensive. NLR is an important measure of proinfl ammatory status. It is cost-effective, readily available, and can be calculated with a simple CBC assay. The relationship between NLR and AAD have been demonstrated before in hypertensive patients. 7 However, until now, these relationship had not been showed in BAV patients.
Study Limitations
This is not a large scale study. Therefore, we can only observe a relationship between study parameters and AAd but can not establish a causal relationship. In addition, only hemoglobin levels were measured in our study; the factors that may be associated with erythrocyte homeostasis such as the levels of iron, ferrition, folat, vitamin B12 and other infl ammatory mediators were not assessed.
